Two Sigma Securities, LLC Biocryst Pharmaceuticals Inc Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $49,481 - $77,410	10,119 New	10,119 $51,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $198,738 - $296,355	25,030 New	25,030 $208,000
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $75,129 - $138,740	-10,194 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $34,353 - $87,770	10,194 New	10,194 $76,000
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $38,110 - $112,525	-20,058 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.6 - $4.11 $32,092 - $82,438	20,058 New	20,058 $40,000

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.